Live Breaking News & Updates on Rare Genetic Disorders

Stay updated with breaking news from Rare genetic disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chief Technical Officer Joseph Shulman Sells Shares of Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity, has reported an insider sell according to a recent SEC filing. ....

Biopharmaceutical Company , Rhythm Pharmaceuticals Inc , Fec Filing , Joseph Shulman , Rare Genetic Disorders , Nsider Transaction ,